News Corona Remedies IPO GMP Charges 28% to ₹300: Pharma Powerhouse’s Dec 8–10 Debut – Cure for Your Portfolio Blues? December 12, 2025 Pharma IPOs are the ultimate resilience play, and Corona Remedies exemplifies why—delivering steady GMP amid market jitters. With my decade-plus expertise in healthcare equities (advising on 150+ listings, including Sun…